Prior to his work with Fluent, Brian spent the last 23 years building successful operating businesses, such as Agencourt Biosciences, Agencourt Personal Genomics, Courtagen Life Sciences and Medicinal Genomics. Several of his companies were significant contributors to the NHGRI’s Human Genome Project, as well as key participants in the global effort to curate gene mutation associations for neurological disease conditions. Brian has overseen and managed the implementation of highly efficient manufacturing and services operations, commercial sales organizations and sophisticated bioinformatics development initiatives. Brian is an operating advisor to Arsenal Capital Partners and is a guest speaker at Columbia Business School. He has served as the Chairman of the Board of the Analytical Life Sciences and Diagnostic Association, holds a BA in Computer Sciences, Business Management and Japanese, as well as an MBA in Finance from Columbia Business School.